ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011

Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed

December 7, 1979

Archival photos: Senator Ernest “Fritz” Hollings, namesake of MUSC Hollings Cancer Center

February 2, 2021

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012

Trials Approved by NCI CTEP Last Month

November 25, 2011